Inactive Instrument

Perrigo Company PLC Stock Nyse

Equities

US7142901039

Pharmaceuticals

End-of-day quote Nyse
- USD - Intraday chart for Perrigo Company PLC
Sales 2024 * 4.62B 6.36B Sales 2025 * 4.84B 6.66B Capitalization 3.67B 5.05B
Net income 2024 * -73M -100M Net income 2025 * 107M 147M EV / Sales 2024 * 1.49 x
Net Debt 2024 * 3.21B 4.42B Net Debt 2025 * 3.01B 4.15B EV / Sales 2025 * 1.38 x
P/E ratio 2024 *
-18.6 x
P/E ratio 2025 *
168 x
Employees -
Yield 2024 *
4.09%
Yield 2025 *
4.35%
Free-Float 99.66%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 55 23-06-29
Director of Finance/CFO 49 22-05-15
Chief Tech/Sci/R&D Officer - 14-12-31
Members of the board TitleAgeSince
Chairman 55 20-12-14
Director/Board Member 68 17-02-05
Director/Board Member 67 17-02-05
More insiders
Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.
More about the company